Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Fox

Showing results (121-130 of 182) with videos related to

Pageof 19
Sort By:
Plos Pathogens|October 3, 2022
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concernCarl Graham, Thomas Lechmere, Aisha Rehman, et al.
Frontiers in Immunology|April 3, 2023
Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 monthsJennifer Serwanga, Violet Ankunda, Jackson Sembera, et al.
AIDS (London, England)|June 15, 2021
Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohortLuke A Granger, Isabella Huettner, Franka Debeljak, et al.
Journal of the International AIDS Society|August 24, 2022
A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and ZimbabweJanan Janine Dietrich, Nadia Ahmed, Emily L Webb, et al.
Mucosal Immunology|June 27, 2019
CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotypeJohn P Thornhill, Matthew Pace, Genevieve E Martin, et al.
AIDS (London, England)|November 8, 2017
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular riskJosé M Gatell, Lambert Assoumou, Graeme Moyle, et al.
The Journal of Infectious Diseases|November 29, 2019
Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory ExpansionGenevieve E Martin, Matthew Pace, Freya M Shearer, et al.
Plos Pathogens|July 15, 2016
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 InfectionMatthias Hoffmann, Nikos Pantazis, Genevieve E Martin, et al.
Frontiers in Immunology|May 22, 2018
CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNAGenevieve E Martin, Matthew Pace, John P Thornhill, et al.
Archives of Sexual Behavior|May 6, 2021
Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South AfricaRichard Muhumuza, Andrew Sentoogo Ssemata, Ayoub Kakande, et al.
Pageof 19

Showing results (121-130 of 182) with videos related to

Sort By:
Pageof 19
Plos Pathogens|October 3, 2022
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concernCarl Graham, Thomas Lechmere, Aisha Rehman, et al.
Frontiers in Immunology|April 3, 2023
Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 monthsJennifer Serwanga, Violet Ankunda, Jackson Sembera, et al.
AIDS (London, England)|June 15, 2021
Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohortLuke A Granger, Isabella Huettner, Franka Debeljak, et al.
Journal of the International AIDS Society|August 24, 2022
A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and ZimbabweJanan Janine Dietrich, Nadia Ahmed, Emily L Webb, et al.
Mucosal Immunology|June 27, 2019
CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotypeJohn P Thornhill, Matthew Pace, Genevieve E Martin, et al.
AIDS (London, England)|November 8, 2017
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular riskJosé M Gatell, Lambert Assoumou, Graeme Moyle, et al.
The Journal of Infectious Diseases|November 29, 2019
Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory ExpansionGenevieve E Martin, Matthew Pace, Freya M Shearer, et al.
Plos Pathogens|July 15, 2016
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 InfectionMatthias Hoffmann, Nikos Pantazis, Genevieve E Martin, et al.
Frontiers in Immunology|May 22, 2018
CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNAGenevieve E Martin, Matthew Pace, John P Thornhill, et al.
Archives of Sexual Behavior|May 6, 2021
Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South AfricaRichard Muhumuza, Andrew Sentoogo Ssemata, Ayoub Kakande, et al.
Pageof 19